|
Volumn 2, Issue 2, 2004, Pages 358-359
|
High-titer inhibitor development in hemophilia A: Lack of product specificity [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 8 DERIVATIVE;
BLOOD CLOTTING INHIBITOR;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
ALLOANTIBODY;
BLOOD CLOTTING FACTOR 8;
ANTIBODY TITER;
DRUG EFFICACY;
DRUG SPECIFICITY;
GENE DELETION;
GENE REARRANGEMENT;
GENETIC PREDISPOSITION;
HEMOPHILIA A;
HUMAN;
LETTER;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
STOP CODON;
BLOOD;
IMMUNOLOGY;
RETROSPECTIVE STUDY;
FACTOR VIII;
HEMOPHILIA A;
HUMANS;
ISOANTIBODIES;
RETROSPECTIVE STUDIES;
|
EID: 4644287905
PISSN: 15387933
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1538-7836.2004.0584g.x Document Type: Letter |
Times cited : (5)
|
References (8)
|